CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AG5. A total of 2 filers reported holding CLOVIS ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $7,000 | -100.0% | 35,000,000 | 0.0% | 0.19% | -29.0% |
| Q3 2022 | $19,381,000 | 0.0% | 35,000,000 | 0.0% | 0.27% | -38.5% |
| Q2 2022 | $19,381,000 | -52.6% | 35,000,000 | -39.1% | 0.44% | -53.6% |
| Q1 2022 | $40,899,000 | -5.5% | 57,500,000 | 0.0% | 0.95% | +0.7% |
| Q4 2021 | $43,286,000 | – | 57,500,000 | – | 0.94% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 57,500,000 | $43,286,000 | 0.94% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |